
[Replay] - Innovative Solutions for Hair Disorders: Exploring New Treatments and AI Technology
During the latest International Forum of Dermatology 2026 that we organized around the thematic "Inventing the Future of Dermatology," many leading and renowned dermatology experts shared their insights on this topic.
Discover below the session dedicated to AI & HAIR and SCALP.
Part 1 - Smart Solutions: AI’s Role in Diagnosing and Managing Hair & Scalp Conditions

Dr. Daniel Fernandes Melo
Dermatologist, Brazil
What you'll learn:
- "Artificial intelligence is becoming an essential tool in trichology, enhancing diagnostic precision through image and pattern recognition."
- "AI-based image analysis improves objectivity, reduces interobserver variability, and supports earlier detection of inflammatory and scarring alopecias."
- "AI should be viewed as a complementary tool that increases."
Part 2 - What Every Dermatologist Should Know About New Therapies for Androgenic Alopecia?

Dr. Sergio Vañó Galván
Dermatologist, Spain - IFD Chairman
What you'll learn:
- “The therapeutic landscape of androgenetic alopecia has changed significantly over the last decade.”
- “New systemic options such as oral minoxidil and oral anti‑androgens, as well as novel topical anti‑androgens and mesotherapy protocols, are reshaping care.”
- “Emerging treatments including exosomes, light‑based therapies, and regenerative medicine broaden the arsenal for both men and women.”
- “Practical therapeutic algorithms help optimize individualized management of male and female androgenetic alopecia.”
Part 3 - New Horizons in Hair Care: Cutting-Edge Therapies for Alopecia Areata and Scarring Alopecias

Dr. Marisa Mathieu
Dermatologist, Belgium
What you'll learn:
- “Early and accurate diagnosis is critical, especially in scarring alopecias where follicular destruction is irreversible.”
- “Novel targeted therapies are transforming the management of alopecia areata and cicatricial alopecias.”
- “Earlier, more precise diagnosis allows better therapeutic strategies and improved long‑term patient outcomes.”
Watch the replay
40 mins
.
Interested in our news?
Discover those of our other brands.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.


